IOVS Journal of Biological Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fautsch, M. P.
Right arrow Articles by Johnson, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fautsch, M. P.
Right arrow Articles by Johnson, D. H.
(Investigative Ophthalmology and Visual Science. 2000;41:4163-4168.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Recombinant TIGR/MYOC Increases Outflow Resistance in the Human Anterior Segment

Michael P. Fautsch, Cindy K. Bahler, David J. Jewison and Douglas H. Johnson

From the Department of Ophthalmology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota.

PURPOSE. To determine the effect of human recombinant TIGR/myocilin (MYOC) protein on outflow resistance in the human anterior segment.

METHODS. A cDNA for MYOC was inserted into a bacterial expression system and purified with nickel ion affinity chromatography. The anterior segments of 12 pairs of human eyes were placed in perfusion organ culture. One eye received an anterior chamber exchange with partially purified recombinant MYOC (25 µg), whereas the other eye received either heat-denatured recombinant MYOC (25 µg), partially purified ß-galactosidase (25 or 250 µg), or partially purified control proteins isolated from a null expression lysate (25 µg). Eyes were fixed up to 72 hours after infusion, and immunohistochemistry was performed using anti-MYOC polyclonal antibody.

RESULTS. Recombinant MYOC caused an increase in IOP over 12 hours, increasing outflow resistance 94%, whereas the fellow eye infused with null expression sample increased 12% (n = 7; P = 0.0005). When compared with recombinant MYOC, neither heat-denatured MYOC, recombinant ß-galactosidase, bovine serum albumin, nor fetal calf serum caused an increase in outflow resistance. MYOC IOP remained above baseline levels for 48 to 72 hours. Immunohistochemistry results confirmed the presence of recombinant MYOC in the trabecular meshwork.

CONCLUSIONS. Recombinant MYOC increased outflow resistance in human anterior segments, whereas control proteins did not. MYOC may increase outflow resistance by specific interactions within the trabecular meshwork.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Zhang, R. Maddala, and P. V. Rao
Novel molecular insights into RhoA GTPase-induced resistance to aqueous humor outflow through the trabecular meshwork
Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1057 - C1070.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W.-H. Wang, L. G. McNatt, I.-H. Pang, P. E. Hellberg, J. H. Fingert, M. D. McCartney, and A. F. Clark
Increased Expression of Serum Amyloid A in Glaucoma and Its Effect on Intraocular Pressure
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1916 - 1923.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Sanchez-Sanchez, F. Martinez-Redondo, J. D. Aroca-Aguilar, M. Coca-Prados, and J. Escribano
Characterization of the Intracellular Proteolytic Cleavage of Myocilin and Identification of Calpain II as a Myocilin-processing Protease
J. Biol. Chem., September 21, 2007; 282(38): 27810 - 27824.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. P. Fautsch, C. K. Bahler, A. M. Vrabel, K. G. Howell, N. Loewen, W. L. Teo, E. M. Poeschla, and D. H. Johnson
Perfusion of His-Tagged Eukaryotic Myocilin Increases Outflow Resistance in Human Anterior Segments in the Presence of Aqueous Humor
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 213 - 221.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. P. Fautsch, K. G. Howell, A. M. Vrabel, M. C. Charlesworth, D. C. Muddiman, and D. H. Johnson
Primary Trabecular Meshwork Cells Incubated in Human Aqueous Humor Differ from Cells Incubated in Serum Supplements
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2848 - 2856.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Zillig, A. Wurm, F. J. Grehn, P. Russell, and E. R. Tamm
Overexpression and Properties of Wild-Type and Tyr437His Mutated Myocilin in the Eyes of Transgenic Mice
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 223 - 234.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. B. Gould, L. Miceli-Libby, O. V. Savinova, M. Torrado, S. I. Tomarev, R. S. Smith, and S. W. M. John
Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma
Mol. Cell. Biol., October 15, 2004; 24(20): 9019 - 9025.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. K. Bahler, M. P. Fautsch, C. R. Hann, and D. H. Johnson
Factors Influencing Intraocular Pressure in Cultured Human Anterior Segments
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3137 - 3143.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Goldwich, C. R. Ethier, D. W.-H. Chan, and E. R. Tamm
Perfusion with the Olfactomedin Domain of Myocilin Does Not Affect Outflow Facility
Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1953 - 1961.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. J. Hillier and V. D. Vacquier
Amassin, an olfactomedin protein, mediates the massive intercellular adhesion of sea urchin coelomocytes
J. Cell Biol., February 18, 2003; 160(4): 597 - 604.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
T. Borras, T. V. Morozova, S. L. Heinsohn, R. F. Lyman, T. F. C. Mackay, and R. R. H. Anholt
Transcription Profiling in Drosophila Eyes That Overexpress the Human Glaucoma-Associated Trabecular Meshwork-Inducible Glucocorticoid Response Protein/Myocilin (TIGR/MYOC)
Genetics, February 1, 2003; 163(2): 637 - 645.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Sohn, W. Hur, M. K. Joe, J.-H. Kim, Z.-W. Lee, K.-S. Ha, and C. Kee
Expression of Wild-Type and Truncated Myocilins in Trabecular Meshwork Cells: Their Subcellular Localizations and Cytotoxicities
Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3680 - 3685.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. S. Filla, X. Liu, T. D. Nguyen, J. R. Polansky, C. R. Brandt, P. L. Kaufman, and D. M. Peters
In Vitro Localization of TIGR/MYOC in Trabecular Meshwork Extracellular Matrix and Binding to Fibronectin
Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 151 - 161.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. G. Ladas, F. Yu, R. Loo, J. L. Davis, A. L. Coleman, R. D. Levinson, and G. N. Holland
Relationship between Aqueous Humor Protein Level and Outflow Facility in Patients with Uveitis
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2584 - 2588.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. P. Fautsch and D. H. Johnson
Characterization of Myocilin-Myocilin Interactions
Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2324 - 2331.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. F. Clark, H. T. Steely, J. E. Dickerson Jr, S. English-Wright, K. Stropki, M. D. McCartney, N. Jacobson, A. R. Shepard, J. I. Clark, H. Matsushima, et al.
Glucocorticoid Induction of the Glaucoma Gene MYOC in Human and Monkey Trabecular Meshwork Cells and Tissues
Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1769 - 1780.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology